The Complete Estrogen Receptor Antagonist Op-1250 Shrinks Tumors In Xenograft Models And Has Favorable Preclinical Pharmacokinetic AttributesLeslie Hodges-Gallagher,Richard Sun,David C. Myles,Pamela M. Klein,Jo Anne Zujewski,Cyrus L. Harmon,Peter J. KushnerCANCER RESEARCH(2021)引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要